Northern Trust Corp Vanda Pharmaceuticals Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 501,159 shares of VNDA stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
501,159
Previous 486,911 2.93%
Holding current value
$2.55 Million
Previous $2.75 Million 14.58%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$4.61 - $6.34 $65,683 - $90,332
14,248 Added 2.93%
501,159 $2.35 Million
Q2 2024

Aug 14, 2024
SELL
$3.91 - $6.5 $30,611 - $50,888
-7,829 Reduced 1.58%
486,911 $2.75 Million
Q1 2024

May 14, 2024
SELL
$3.47 - $4.61 $48,042 - $63,825
-13,845 Reduced 2.72%
494,740 $2.03 Million
Q4 2023

Feb 13, 2024
SELL
$3.38 - $4.58 $178,301 - $241,604
-52,752 Reduced 9.4%
508,585 $2.15 Million
Q3 2023

Nov 13, 2023
SELL
$4.28 - $6.57 $146,217 - $224,450
-34,163 Reduced 5.74%
561,337 $2.42 Million
Q2 2023

Aug 11, 2023
SELL
$5.9 - $6.95 $4,619 - $5,441
-783 Reduced 0.13%
595,500 $3.92 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $63,406 - $81,977
10,260 Added 1.75%
596,283 $4.05 Million
Q4 2022

Feb 13, 2023
SELL
$6.87 - $10.96 $58,855 - $93,894
-8,567 Reduced 1.44%
586,023 $4.33 Million
Q3 2022

Nov 14, 2022
SELL
$9.44 - $11.76 $24,081 - $29,999
-2,551 Reduced 0.43%
594,590 $5.88 Million
Q2 2022

Aug 12, 2022
BUY
$9.31 - $11.84 $2,159 - $2,746
232 Added 0.04%
597,141 $6.51 Million
Q1 2022

May 13, 2022
SELL
$10.84 - $16.55 $2.12 Million - $3.23 Million
-195,342 Reduced 24.66%
596,909 $6.75 Million
Q4 2021

Feb 08, 2022
SELL
$15.69 - $21.14 $113,297 - $152,651
-7,221 Reduced 0.9%
792,251 $12.4 Million
Q3 2021

Nov 15, 2021
SELL
$15.35 - $21.27 $317,453 - $439,884
-20,681 Reduced 2.52%
799,472 $13.7 Million
Q2 2021

Aug 13, 2021
BUY
$15.71 - $21.51 $3.06 Million - $4.18 Million
194,483 Added 31.08%
820,153 $17.6 Million
Q1 2021

May 12, 2021
SELL
$13.42 - $20.28 $329,622 - $498,117
-24,562 Reduced 3.78%
625,670 $9.4 Million
Q4 2020

Feb 11, 2021
SELL
$9.77 - $13.81 $329,200 - $465,327
-33,695 Reduced 4.93%
650,232 $8.54 Million
Q3 2020

Nov 16, 2020
SELL
$9.32 - $12.02 $257,455 - $332,040
-27,624 Reduced 3.88%
683,927 $6.61 Million
Q2 2020

Aug 14, 2020
SELL
$9.66 - $12.02 $82,351 - $102,470
-8,525 Reduced 1.18%
711,551 $8.14 Million
Q1 2020

May 14, 2020
BUY
$7.5 - $16.8 $30,945 - $69,316
4,126 Added 0.58%
720,076 $7.46 Million
Q4 2019

Feb 14, 2020
SELL
$12.38 - $17.47 $210,249 - $296,693
-16,983 Reduced 2.32%
715,950 $11.7 Million
Q3 2019

Nov 13, 2019
BUY
$12.27 - $15.79 $322,296 - $414,755
26,267 Added 3.72%
732,933 $9.73 Million
Q2 2019

Aug 13, 2019
BUY
$13.37 - $18.85 $92,761 - $130,781
6,938 Added 0.99%
706,666 $9.96 Million
Q1 2019

May 13, 2019
BUY
$17.59 - $31.05 $75,461 - $133,204
4,290 Added 0.62%
699,728 $12.9 Million
Q4 2018

Feb 12, 2019
SELL
$18.97 - $31.47 $124,879 - $207,167
-6,583 Reduced 0.94%
695,438 $18.2 Million
Q3 2018

Nov 14, 2018
BUY
$18.25 - $23.0 $469,408 - $591,583
25,721 Added 3.8%
702,021 $16.1 Million
Q2 2018

Sep 18, 2018
SELL
$13.95 - $19.15 $37,023 - $50,824
-2,654 Reduced 0.39%
676,300 $12.9 Million
Q2 2018

Aug 14, 2018
BUY
$13.95 - $19.15 $1.31 Million - $1.8 Million
94,193 Added 16.11%
678,954 $12.9 Million
Q1 2018

May 09, 2018
BUY
$14.05 - $20.2 $94,556 - $135,946
6,730 Added 1.16%
584,761 $9.85 Million
Q4 2017

Feb 14, 2018
SELL
$12.85 - $18.1 $176,751 - $248,965
-13,755 Reduced 2.32%
578,031 $8.79 Million
Q3 2017

Nov 13, 2017
BUY
$15.4 - $18.85 $9.11 Million - $11.2 Million
591,786
591,786 $10.6 Million

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $288M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email